If you’ve ever looked in the mirror and wondered, “Is it too early—or too late—to start wrinkle relaxers?” you’re not alone. It’s one of the most common questions dermatologists hear, and the answer isn’t about chasing trends or erasing expression. It’s about understanding your skin and making informed, confident choices.
Toxins, including neuromodulators like Botox® and Jeaveau®, are among the most widely used cosmetic dermatology treatments, with millions of treatments performed each year. By relaxing targeted facial muscles that contribute to expression lines, toxins help soften the appearance of wrinkles over time—most commonly in areas like frown lines, crow’s feet, and forehead lines.
When is the right time to start?
Patients must be at least 18 to receive toxin treatments, but many begin considering preventative treatments in their late 20s or early 30s, especially if they’re noticing early expression lines. Used preventatively, these treatments can help reduce repetitive muscle movement before lines become deeply set, supporting smoother-looking skin over time.
“The best time to start toxins is when it makes sense for your skin—not based on a number,” says Dr. Ashley Dietrich, board-certified dermatologist at Forefront Dermatology. “Our goal is always natural-looking results that help patients feel like the best version of themselves.”
In your 30s, toxins often help address early expression lines caused by smiling, squinting, or lifting the brows. In your 40s and beyond, these treatments may be paired with other dermatologist-led treatments to support more comprehensive rejuvenation—always with a focus on balance and subtlety.
Cosmetic dermatology you can trust
At Forefront Dermatology, cosmetic care starts with the same clinical expertise and thoughtful evaluation you expect from a dermatology check-up. From subtle refreshers to more advanced treatments, every plan is designed around you—delivering results you’ll love, guided by care you can trust.
Find a location near you and book your appointment today.





